Clinical and mutational spectrum of highly differentiated, paired box 3:forkhead box protein o1 fusion-negative rhabdomyosarcoma: A report from the Children's Oncology Group-Reference-Cited by-同舟云学术

Clinical and mutational spectrum of highly differentiated, paired box 3:forkhead box protein o1 fusion-negative rhabdomyosarcoma: A report from the Children's Oncology Group

Published:2018-02-20 Issue:9 Volume:124 Page:1973-1981
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Teot Lisa A.¹,Schneider Michaela²,Thorner Aaron R.³,Tian Jing⁴,Chi Yueh-Yun⁴,Ducar Matthew³,Lin Ling³,Wlodarski Marcin²,Grier Holcombe E.⁵,Fletcher Christopher D. M.⁶,van Hummelen Paul³,Skapek Stephen X.⁷,Hawkins Douglas S.⁸⁹,Wagers Amy J.¹⁰¹¹¹²,Rodriguez-Galindo Carlos¹³,Hettmer Simone²^ORCID

Affiliation:

1. Department of Pathology; Boston Children's Hospital; Boston Massachusetts

2. Division of Pediatric Hematology and Oncology, Department of Pediatric and Adolescent Medicine, Faculty of Medicine; University of Freiburg; Germany

3. Center for Cancer Genome Discovery; Dana-Farber Cancer Institute; Boston Massachusetts

4. Department of Biostatistics; University of Florida; Gainesville Florida

5. Dana-Farber/Boston Children's Cancer and Blood Disorders Center; Boston Massachusetts

6. Department of Pathology; Brigham and Women's Hospital; Boston Massachusetts

7. Division of Hematology/Oncology, Children's Medical Center; University of Texas Southwestern Medical Center; Dallas Texas

8. Division of Hematology/Oncology, Seattle Children's Hospital; University of Washington; Seattle Washington

9. Fred Hutchinson Cancer Center; Seattle Washington

10. Harvard Stem Cell Institute; Cambridge Massachusetts

11. Department of Stem Cell and Regenerative Biology; Joslin Diabetes Center; Boston Massachusetts

12. Paul F. Glenn Center for the Biology of Aging at Harvard Medical School; Boston Massachusetts

13. Department of Global Pediatric Medicine; St. Jude Children's Research Hospital; Memphis Tennessee

Funder

Joslin Diabetes Center

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference36 articles.

1. Rhabdomyosarcoma: current challenges and their implications for developing therapies;Hettmer;Cold Spring Harb Perspect Med.,2014

2. Pathologic classification of rhabdomyosarcomas and correlations with molecular studies;Parham;Mod Pathol.,2001

3. Targeting oxidative stress in embryonal rhabdomyosarcoma;Chen;Cancer Cell.,2013

4. Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors;Shern;Cancer Discov.,2014

5. Distinct malignant behaviors of mouse myogenic tumors induced by different oncogenetic lesions;Hettmer;Front Oncol.,2015

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hedgehog signaling in tissue homeostasis, cancers, and targeted therapies;Signal Transduction and Targeted Therapy;2023-08-18

2. Changes on chromosome 11p15.5 as specific marker for embryonal rhabdomyosarcoma?;Genes, Chromosomes and Cancer;2023-08-02

3. Genetic susceptibility in children, adolescents, and young adults diagnosed with soft-tissue sarcomas;European Journal of Medical Genetics;2023-05

4. Targeting the Hedgehog Pathway in Rhabdomyosarcoma;Cancers;2023-01-24

5. FANCC and PTCH1 gene loss in congenital infantile rhabdomyosarcoma with spindle cell features;Pediatric Blood & Cancer;2022-11-03